Rebleeding after initial aneurysmal subarachnoid hemorrhage (SAH) can have substantial impact on overall patient outcome. While older studies have suggested rebleeding occurs in about 4% of patients during the first day after initial aneurysmal bleed, these studies may have failed to capture very early rebleeds and, consequently, underestimated the impact of rebleeding. An electronic literature search was performed to identify English-language articles published or available for review from February 1975 through October 2010. A total of 43 articles (40 original research and 3 review articles) focused on rebleeding after initial aneurysmal SAH in humans were selected for review. Although most studies supported an incidence of rebleeding ≤4%, studies investigating ultra-early rebleeding reported bleeding within the first 24 h following aneurysmal SAH in as many as 9-17% of patients, with most cases occurring within 6 h of initial hemorrhage. Overall, studies investigating antifibrinolytic therapy to reduce rebleeding have failed to clearly demonstrate overall therapeutic benefit. Short-course antifibrinolytic therapy may have a role prior to initial aneurysm repair, although insufficient data are currently available. © Springer Science+Business Media, LLC 2011.

Starke, R., Connolly J. r., E., Citerio, G. (2011). Rebleeding after aneurysmal subarachnoid hemorrhage. NEUROCRITICAL CARE, 15(2), 241-246 [10.1007/s12028-011-9581-0].

Rebleeding after aneurysmal subarachnoid hemorrhage

CITERIO, GIUSEPPE
2011

Abstract

Rebleeding after initial aneurysmal subarachnoid hemorrhage (SAH) can have substantial impact on overall patient outcome. While older studies have suggested rebleeding occurs in about 4% of patients during the first day after initial aneurysmal bleed, these studies may have failed to capture very early rebleeds and, consequently, underestimated the impact of rebleeding. An electronic literature search was performed to identify English-language articles published or available for review from February 1975 through October 2010. A total of 43 articles (40 original research and 3 review articles) focused on rebleeding after initial aneurysmal SAH in humans were selected for review. Although most studies supported an incidence of rebleeding ≤4%, studies investigating ultra-early rebleeding reported bleeding within the first 24 h following aneurysmal SAH in as many as 9-17% of patients, with most cases occurring within 6 h of initial hemorrhage. Overall, studies investigating antifibrinolytic therapy to reduce rebleeding have failed to clearly demonstrate overall therapeutic benefit. Short-course antifibrinolytic therapy may have a role prior to initial aneurysm repair, although insufficient data are currently available. © Springer Science+Business Media, LLC 2011.
Articolo in rivista - Articolo scientifico
Antifibrinolytic; Predictor; Ultra-early rebleeding; Acute Disease; Antifibrinolytic Agents; Critical Care; Humans; Incidence; Recurrence; Risk Factors; Subarachnoid Hemorrhage; Embolization, Therapeutic; Neurology (clinical); Critical Care and Intensive Care Medicine
English
2011
15
2
241
246
reserved
Starke, R., Connolly J. r., E., Citerio, G. (2011). Rebleeding after aneurysmal subarachnoid hemorrhage. NEUROCRITICAL CARE, 15(2), 241-246 [10.1007/s12028-011-9581-0].
File in questo prodotto:
File Dimensione Formato  
Neurocrit Care 2011 Starke.pdf

Solo gestori archivio

Dimensione 181.03 kB
Formato Adobe PDF
181.03 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/54819
Citazioni
  • Scopus 92
  • ???jsp.display-item.citation.isi??? 79
Social impact